Patents by Inventor Darlene Deecher

Darlene Deecher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Characterization of a membrane estrogen receptor
    Publication number: 20060287226
    Abstract: The present invention discloses the identification of a novel membrane associated estrogen receptor, termed mER. The membrane associated receptor is involved in rapid signal transduction. Amino acid sequences, nucleic acid sequences, vectors, and host cells are also discussed. Additionally, methods of detecting agonists and antagonists for the receptor are disclosed herein.
    Type: Application
    Filed: June 14, 2002
    Publication date: December 21, 2006
    Inventors: Darlene Deecher, Pamela Swiggard, Donald Frail, Lawrence O'Connor
  • Characterization of a membrane estrogen receptor
    Publication number: 20060116317
    Abstract: The present disclosure relates to a process for dyeing keratin materials with compositions comprising, in a medium that is suitable for dyeing, at least one ninhydrin derivative, which may optionally be combined with at least one compound comprising at least one labile hydrogen. Further disclosed herein are dying compositions, multi-component hair dye compositions, and a multi-compartment kits.
    Type: Application
    Filed: June 14, 2002
    Publication date: June 1, 2006
    Inventors: Darlene Deecher, Pamela Swiggard, Donald Frail, Lawrence O'Connor
  • Method for treating nervous system disorders and conditions
    Publication number: 20060019966
    Abstract: The present invention is directed to selective dopamine reuptake inhibitors, including (?)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, (?)-1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, and methods of their use for treating certain nervous system disorders and conditions, including, inter alia, vasomotor symptoms (VMS), chronic pain, and Shy Drager syndrome.
    Type: Application
    Filed: July 21, 2005
    Publication date: January 26, 2006
    Applicant: Wyeth
    Inventors: Darlene Deecher, Magid Abou-Gharbia
  • Method for treating nervous system disorders and conditions
    Publication number: 20060020014
    Abstract: The present invention is directed to racemic 1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, racemic 1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and (+)-1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and methods of their use for treating certain nervous system disorders and conditions, including, inter alia, vasomotor symptoms (VMS) and chronic pain.
    Type: Application
    Filed: July 21, 2005
    Publication date: January 26, 2006
    Applicant: Wyeth
    Inventors: Magid Abou-Gharbia, Arthur Cohn, Darlene Deecher
  • Method for treating nervous system disorders and conditions
    Publication number: 20060020015
    Abstract: The present invention is directed to racemic 1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, racemic 1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and (+)-1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and methods of their use for treating certain nervous system disorders and conditions, including, inter alia, vasomotor symptoms (VMS) and chronic pain.
    Type: Application
    Filed: July 21, 2005
    Publication date: January 26, 2006
    Applicant: Wyeth
    Inventors: Magid Abou-Gharbia, Arthur Cohn, Darlene Deecher
  • Methods of treating vasomotor symptoms
    Publication number: 20050130987
    Abstract: The present invention relates to selective adrenergica2B antagonists alone, selective adrenergic?2B antagonists in combination with norepinephrine reuptake inhibitors (NRI) (as a single compound or as a combination of two or more compounds), or selective adrenergic?2B antagonists in combination with dual norepinephrine reuptake inhibitors/serotonin reuptake inhibitors (NRI/SRI) (as a single compound or as a combination of two or more compounds) and methods of their use in the treatment of vasomotor symptoms.
    Type: Application
    Filed: October 12, 2004
    Publication date: June 16, 2005
    Applicant: Wyeth
    Inventors: Darlene Deecher, Chad Beyer, Liza Leventhal
  • CHARACTERIZATION OF A MEMBRANE ESTROGEN RECEPTOR
    Publication number: 20050096265
    Abstract: Abstract of the Disclosure The present invention discloses the identification of a novel membrane associated estrogen receptor, termed mER. The membrane associated receptor is involved in rapid signal transduction. Amino acid sequences, nucleic acid sequences, vectors, and host cells are also discussed. Additionally, methods of detecting agonists and antagonists for the receptor are disclosed herein.
    Type: Application
    Filed: February 9, 2004
    Publication date: May 5, 2005
    Applicant: Wyeth
    Inventors: Darlene Deecher, Pamela Swiggard, Donald Frail, Lawrence O'Connor